Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Germline Pharmacogenetic Studies
- Citation:
- J Natl Cancer Inst vol 107 (2)
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- collection
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U24CA196171, U10CA180821, U10CA180882, UL1 TR000430, CA116201, U01GM61393, U10 CA180821, R01 CA133049, P50 CA058223, P50 CA098131, P30 CA015083, U10 CA180882, U24 CA196171, CA058223, U10 CA180838, 1R01CA133049-01
- Corr. Author:
- Authors:
- Matthew P. Goetz James X. Sun Vera J. Suman Grace O. Silva Charles M. Perou Yusuke Nakamura Nancy J. Cox Philip J. Stephens Vincent A. Miller Jeffrey S. Ross David Chen Stephanie L. Safgren Mary J. Kuffel Matthew M. Ames Krishna R. Kalari Henry L. Gomez Ana M. Gonzalez-Angulo Octavio Burgues Hiltrud B. Brauch James N. Ingle Mark J. Ratain Roman Yelensky
- Networks:
- Study
- NCCTG-89-30-52
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Article